Marion Delenclos - Related publications

Aarhus University, Aarhus, Denmark 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
10 most relevant papers in past 60 days:
Year Citation  Score
2022 Kim C, Hovakimyan A, Zagorski K, Antonyan T, Petrushina I, Davtyan H, Chailyan G, Hasselmann J, Iba M, Adame A, Rockenstein E, Szabo M, Blurton-Jones M, Cribbs DH, Ghochikyan A, et al. Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies. Npj Vaccines. 7: 1. PMID 35013319 DOI: 10.1038/s41541-021-00424-2   
2022 Laferrière F, Claverol S, Bezard E, De Giorgi F, Ichas F. Similar neuronal imprint and no cross-seeded fibrils in α-synuclein aggregates from MSA and Parkinson's disease. Npj Parkinson's Disease. 8: 10. PMID 35027576 DOI: 10.1038/s41531-021-00264-w   
2022 Karikari AA, McFleder RL, Ribechini E, Blum R, Bruttel V, Knorr S, Gehmeyr M, Volkmann J, Brotchie JM, Ahsan F, Haack B, Monoranu CM, Keber U, Yeghiazaryan R, Pagenstecher A, et al. Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease mice. Brain, Behavior, and Immunity. PMID 35032575 DOI: 10.1016/j.bbi.2022.01.007   
2022 Tu H, Zhang ZW, Qiu L, Lin Y, Jiang M, Chia SY, Wei Y, Ng ASL, Reynolds R, Tan EK, Zeng L. Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies. Bmc Neuroscience. 23: 3. PMID 34983390 DOI: 10.1186/s12868-021-00687-4   
2022 Konstantin Nissen S, Farmen K, Carstensen M, Schulte C, Goldeck D, Brockmann K, Romero-Ramos M. Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition. Brain, Behavior, and Immunity. PMID 35026420 DOI: 10.1016/j.bbi.2022.01.005   
2022 Giacomelli E, Vahsen BF, Calder EL, Xu Y, Scaber J, Gray E, Dafinca R, Talbot K, Studer L. Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation. Cell Stem Cell. 29: 11-35. PMID 34995492 DOI: 10.1016/j.stem.2021.12.008   
2022 El-Hakim Y, Bake S, Mani KK, Sohrabji F. Impact of intestinal disorders on central and peripheral nervous system diseases. Neurobiology of Disease. 105627. PMID 35032636 DOI: 10.1016/j.nbd.2022.105627   
2022 Kim H, Fraser S. Neural correlates of dual-task walking in people with central neurological disorders: a systematic review. Journal of Neurology. PMID 34989867 DOI: 10.1007/s00415-021-10944-5   
2022 Nozal V, Martínez-González L, Gomez-Almeria M, Gonzalo-Consuegra C, Santana P, Chaikuad A, Pérez-Cuevas E, Knapp S, Lietha D, Ramírez D, Petralla S, Monti B, Gil C, Martín-Requero A, Palomo V, et al. TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy. Journal of Medicinal Chemistry. PMID 34978799 DOI: 10.1021/acs.jmedchem.1c01942   
2022 Tang JJ, Huang LF, Deng JL, Wang YM, Guo C, Peng XN, Liu Z, Gao JM. Cognitive enhancement and neuroprotective effects of OABL, a sesquiterpene lactone in 5xFAD Alzheimer's disease mice model. Redox Biology. 50: 102229. PMID 35026701 DOI: 10.1016/j.redox.2022.102229